Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,910.00
+55.00 (1.43%)
Last updated: Dec 8, 2025, 11:32 AM KST
17.24%
Market Cap59.85B
Revenue (ttm)205.21B
Net Income (ttm)-1.37B
Shares Out15.33M
EPS (ttm)-91.41
PE Ration/a
Forward PEn/a
Dividend75.00 (1.92%)
Ex-Dividend DateDec 29, 2025
Volume64,539
Average Volume40,791
Open3,855.00
Previous Close3,855.00
Day's Range3,830.00 - 4,000.00
52-Week Range3,070.00 - 6,130.00
Beta0.54
RSI60.01
Earnings Daten/a

About Korea Arlico Pharm

Korea Arlico Pharm Co.,Ltd. engages in the researches and develops, produces, and sells medicines in South Korea. It offers ETC, OTC, medical device, and other products; and active ingredients. The company provides products in the areas of circulatory system, anti-platelet, dementia, muscle relaxants, diabetes, NSAIDS and analgesics, ointment/cream, respiratory system, gastrointestinal, metabolic disease, antihistamines, anti-virus, genitourinary, alopecia, psychoneurotic, CNS, anthelmintics, and hypnotic diseases. Korea Arlico Pharm Co.,Ltd. w... [Read more]

Industry Pharmaceutical Preparations
Founded 1992
Employees 112
Stock Exchange KOSDAQ
Ticker Symbol 260660
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.